Multidisciplinary Laboratory of Pharmaceutical Sciences, Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Hiscia Institute, Society for Cancer Research, Arlesheim, Switzerland.
BMC Complement Med Ther. 2020 Jul 9;20(1):215. doi: 10.1186/s12906-020-02987-4.
Viscum album L. (Santalaceae), commonly known as mistletoe, is a hemiparasitic plant traditionally used in complementary cancer treatment. Its antitumor potential is mostly attributed to the presence of aqueous soluble metabolites; however, the use of ethanol as solvent also permits the extraction of pharmacological compounds with antitumor potential. The clinical efficacy of mistletoe therapy inspired the present work, which focuses on ethanolic extracts (V. album "mother tinctures", MT) prepared from different host trees.
Samples from three European subspecies (album, austriacum, and abietis) were harvested, and five different V. album-MT strains were prepared. The following phytochemical analyses were performed: thin layer chromatography (TLC), high-performance liquid chromatography (HPLC) and liquid chromatography-high resolution mass spectrometry (LC-HRMS). The proliferation assay was performed with WST-1 after incubation of tumor (Yoshida and Molt-4) and fibroblast cell lines (NIH/3 T3) with different MT concentrations (0.5 to 0.05% v/v). The cell death mechanism was investigated by flow cytometry (FACS) using Annexin V-7AAD.
Chemical analyses of MT showed the presence of phenolic acids, flavonoids and lignans. The MT flavonoid and viscotoxin contents (mg/g fresh weight) were highest in Quercus robur (9.67 ± 0.85 mg/g) and Malus domestica (3.95 ± 0.58 mg/mg), respectively. The viscotoxin isoform proportions (% total) were also different among the VA subspecies with a higher content of A3 in V. album growing on Abies alba (60.57 ± 2.13). The phytochemical compounds as well as the viscotoxin contents are probably related to the antitumor effects of MT. The cell death mechanisms evaluated by colorimetric and FACS methodologies involved necrotic damage, which was host tree-, time- and dose- dependent, with different selectivity to tumor cells. Mother tincture from V. album ssp. abietis was the most effective at inducing in vitro cellular effects, even when incubated at the smallest concentration tested, probably because of the higher content of VT A3.
Our results indicate the promising antitumor potential of Viscum album ethanolic extracts and the importance of botanical and phytochemical characterization for in vitro anti-proliferative effects.
槲寄生(桑寄生科)俗称槲寄生,是一种半寄生植物,传统上用于癌症的辅助治疗。其抗肿瘤潜力主要归因于水溶性代谢物的存在;然而,使用乙醇作为溶剂也可以提取具有抗肿瘤潜力的药理化合物。槲寄生治疗的临床疗效激发了本工作的开展,本工作重点研究了来自三种欧洲亚种(album、austriacum 和 abietis)的不同宿主树制备的槲寄生乙醇提取物(V. album“母酊剂”,MT)。
采集了三种欧洲亚种的样品,并制备了五种不同的 V. album-MT 菌株。进行了以下植物化学分析:薄层色谱(TLC)、高效液相色谱(HPLC)和液相色谱-高分辨率质谱(LC-HRMS)。采用 WST-1 增殖试验,在不同 MT 浓度(0.5 至 0.05%v/v)下孵育肿瘤(Yoshida 和 Molt-4)和成纤维细胞系(NIH/3T3)后进行。通过使用 Annexin V-7AAD 的流式细胞术(FACS)研究细胞死亡机制。
MT 的化学分析表明存在酚酸、类黄酮和木脂素。槲寄生 MT 中的黄酮类化合物和粘性毒素含量(mg/g 鲜重)以 Quercus robur(9.67±0.85mg/g)和 Malus domestica(3.95±0.58mg/mg)最高。VA 亚种中的粘性毒素异构体比例(%总)也不同,生长在 Abies alba 上的 V. album A3 含量较高(60.57±2.13)。植物化学化合物以及粘性毒素含量可能与 MT 的抗肿瘤作用有关。通过比色法和 FACS 方法评估的细胞死亡机制涉及坏死损伤,这种损伤取决于宿主树、时间和剂量,对肿瘤细胞具有不同的选择性。V. album ssp. abietis 的母酊剂在诱导体外细胞效应方面最为有效,即使在测试的最小浓度下孵育也是如此,这可能是由于 VT A3 的含量较高。
我们的结果表明槲寄生乙醇提取物具有有前途的抗肿瘤潜力,并且植物学和植物化学表征对于体外抗增殖作用很重要。